For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Control Group | Control group. Will not receive the fibrin spray. | None | None | 0 | 27 | 0 | 27 | View |
| Treatment Group--Evicel Fibrin Spray | Patient will receive the fibrin spray after implantation of device but before the wound is closed. Patients will be randomized to receive spray or not and postop parameters measured. Evicel Fibrin Spray: 10cc syringe dose, once at the end of TKA | None | None | 0 | 25 | 0 | 25 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Superficial Wound Dehiscence | None | Skin and subcutaneous tissue disorders | None | View |